# Comparison of Thrombgolytic and Anticoagulation Therapy in Submassive Pulmonary Embolism

> **NCT02132689** · PHASE4 · COMPLETED · sponsor: **University Hospital Ostrava** · enrollment: 100 (actual)

## Conditions studied

- Pulmonary Embolism

## Interventions

- **DRUG:** Actilyse (Thrombolytic therapy)
- **DRUG:** Heparine (Standard anticoagulation therapy)

## Key facts

- **NCT ID:** NCT02132689
- **Lead sponsor:** University Hospital Ostrava
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2015-05
- **Final completion:** 2015-12
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2018-03-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02132689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02132689, "Comparison of Thrombgolytic and Anticoagulation Therapy in Submassive Pulmonary Embolism". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02132689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*